Abpro Holdings, Inc.

ABPO · OTC · SIC 2836: Biological Products, (No Diagnostic Substances)
99
SEC Filings
$0.177444
Close 2026-06-01

Business Summary

PART I Unless otherwise indicated or the context otherwise requires, references in this section to Abpro, Legacy Abpro, we, us, our and other similar terms refer to Abpro Corporation prior to the Merger and to New Abpro and its consolidated subsidiaries or the Company after giving effect to the Merger on November 13, 2024. Merger On November 13, 2024, Atlantic Coastal Acquisition Corp. II, a Delaware corporation (ACAB) and Legacy Abpro completed the closing of the merger between ACAB and Abpro C...

Latest Stock Quote

ABPO 2026-06-01 $0.177444 O:$0.1993 H:$0.2192 L:$0.177444 Vol:0.0M VWAP:$0.1898
origin leaf: 361b73f2352d24c9fcf78f139c96d6341734bbcd3cd7f34fd404624a32af5401

Next Earnings

Q2 FY2026 — expected 2026-07-23

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-04-152024-12-310001213900-25-032133EDGAR103K words
2024-03-292023-12-310001193125-24-081194EDGAR
2023-04-032022-12-310001193125-23-088454EDGAR
2022-03-252021-12-310001193125-22-084159EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001213900-25-110972EDGAR35K words
2025-08-132025-06-300001213900-25-075691EDGAR
2025-05-152025-03-310001213900-25-044318EDGAR
2024-11-262024-09-300001213900-24-102370EDGAR
2024-08-232024-06-300001193125-24-206165EDGAR
2024-07-092024-03-310001193125-24-176812EDGAR
2023-12-152023-09-300001193125-23-296620EDGAR
2023-08-222023-06-300001193125-23-218080EDGAR
2023-05-222023-03-310001193125-23-150482EDGAR
2022-11-102022-09-300001193125-22-282585EDGAR
2022-08-112022-06-300001193125-22-217578EDGAR
2022-05-202022-03-310001193125-22-156322EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-200001213900-26-018819EDGAR1K words
2026-02-110001213900-26-014903EDGAR
2026-02-030001213900-26-011462EDGAR
2026-01-230001213900-26-007215EDGAR
2026-01-060001213900-26-001570EDGAR
2025-12-150001213900-25-121446EDGAR
2025-12-090001213900-25-119439EDGAR
2025-11-040001213900-25-105590EDGAR
2025-11-030001213900-25-104887EDGAR
2025-10-220001213900-25-101285EDGAR

99 total filings indexed. 73 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABOS — Acumen Pharmaceuticals, Inc.

Company Identity

CIK0001893219
TickerABPO
ExchangeOTC
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: aa4c016715893d0f1d55f994cdb981edf347643ab3a2bdd4dc848e7fa4bbe9ab
parent: a816583e672ab332457c92691e0071c1a9030de3d6fe28b12c7952168296b1a0
content hash: c6531b116056d63b9009e8fcc69a9d64b2ce4e490e4b79941188ce91e55d7a71
signed: 2026-06-02T19:00:02.653Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf